ABT vs STRA · P/E 25, rev $44.33B vs P/E 13, rev $1.22B
Abbott Laboratories (ABT) versus Strategic Education Inc (STRA) — a side-by-side from cached financials, not a winner call.
Abbott Laboratories (ABT) is a medical devices company listed on NYSE.
Strategic Education Inc (STRA) is a education & training services company listed on NASDAQ.
Latest reported ABT revenue for 2025-12-31 was $44.33B. Net income was $6.52B. Revenue was up 5.7% from 2024-12-31 to 2025-12-31. ABT currently screens at market cap $154.15B and trailing P/E 24.8.
Latest reported STRA revenue for 2024-12-31 was $1.22B. Net income was $112.7M. Revenue was up 7.7% from 2023-12-31 to 2024-12-31. STRA currently screens at market cap $1.71B and trailing P/E 13.3.
ABT currently screens at market cap $154.15B and trailing P/E 24.8. STRA currently screens at market cap $1.71B and trailing P/E 13.3.
Not investment advice. Open the ABT and STRA stock pages for the full models.
Not investment advice.